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Abstract
Background: The mechanism that initiates human parturition has been proposed to be 'functional
progesterone withdrawal' whereby the 116 kDa B-isoform of the progesterone receptor (PR-B)
switches in favour of the 94 kDa A-isoform (PR-A) in reproductive tissues. Recently, other PR
isoforms, PR-S, PR-C and PR-M generated from the same gene have been identified and partially
characterised.
Methods and Results: Using immunohistochemical, western blotting and RT-PCR techniques,
evidence is provided that indicates the major PR isoform present in human term fetal membranes
(amnion and chorion) and syncytiotrophoblast of the placenta is neither of the classical nuclear PR-
B or PR-A isoforms but is the N-terminally truncated 60 kDa PR-C isoform. Evidence is also
provided that this 60 kDa isoform resides in the cytoplasm of the expressing cell types. Data are
also presented to show that PR-B, PR-A and PR-S isoforms are essentially absent from the amnion
and chorion, whereas PR isoforms A, B, C and S are all present in the decidua, with PR-A being the
major isoform. The syncytiotrophoblast of the placenta contains the cytoplasmic 60 kDa isoform,
but not isoforms PR-A, PR-B or PR-S.
Conclusion: The major PR isoform in the amnion, chorion and placenta is a 60 kDa protein that
could be PR-C, suggesting that the cytoplasmic isoform has a specific role in extra-embryonic
tissues and may be involved in the regulation of human parturition.
Background
Progesterone receptors (PRs) are members of a super-
family of ligand-activated nuclear transcription factors
comprised of specific domains involved in DNA binding,
hormone binding, and transactivation [1]. Progesterone
activation of PR in target tissues is mediated via dimerisa-
tion and phosphorylation of the receptor, resulting in
binding to cis-acting progesterone response elements on
DNA and the modulation of the promoters of target genes
[1,2]. The human PR-A isoform differs from the PR-B iso-
form in lacking the first 164 amino acids contained in PR-
B [3]. Both are translated from distinct mRNA transcripts
generated from a single gene under the control of separate
oestrogen sensitive promoters [4]. Previous work has
identified three additional AUG codons that act as trans-
lation sites with a possible methionine site at amino acid
595 that is predicted to generate a protein of approxi-
mately 60 kDa [5,6]. More recently, two additional trans-
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lational start sites at amino acids 289 and 301 have been
identified that also produce proteins of approximately 60
kDa [7].
Although much work has been performed on PR-B and
PR-A, little work has been undertaken on the other seven
transcripts generated from the PR gene [5], despite there
being evidence that some of these are translated into func-
tional 38 kDa, 60 kDa, 71 kDa or 78 kDa proteins in
malignant progesterone target tissues [8,9] and that these
are co-ordinately up-regulated by oestrogens and down-
regulated by progestins [10,11]. Evidence also exists for
other PR isoforms such as PR-C, PR-S and PR-T, which
could be genomic mediators of progestin action [12,13]
and for three membrane progestin receptors that are clas-
sical G-coupled protein receptor-transduction molecules
first identified in the teleost oocyte called mPRα, mPRβ
and mPRγ [14,15].
Progesterone receptors have been proposed to play a key
role in the control of human labour and parturition
whereby the levels of the PR-B isoform, which is often
considered to be the dominant isoform, fall prior to and
during labour leaving the PR-A isoform as the predomi-
nant form leading to a 'functional progesterone receptor
withdrawal' [16]. Evidence to support this occurring in the
uterine myometrium exists [17], although more recent
evidence suggests that the PR-C isoform is also expressed
and may have a functional role [18,19]. In other human
reproductive tissues, such as the decidua, ovary and the
oviduct [20,21], PR-A appears to be the predominant pro-
gestin regulator with PR-B maintaining a supporting role
suggesting that progestin signalling in the human uterus
at the end of parturition is far more complex than a PR-B
to PR-A isoform switching mechanism [17]. Despite there
being a paucity of data to support 'functional progester-
one receptor withdrawal' in tissues at the fetal-maternal
interface, i.e. in the fetal membranes, decidua and pla-
centa, many still consider that only the PR-B and PR-A iso-
forms are present [22,23].
Recent data have suggested that at least five nuclear PR-
isoforms are present in the human decidua and that all
five isoforms are decreased after labour [24,25]. However,
although western blotting techniques also indicated the
presence of several PR isoforms in amniotic nuclear
extracts, immunohistochemical methods failed to detect
any PR isoforms in the amnion and chorion [25].
In the present study examining the pattern of expression
of PR isoforms in human fetal membranes (amnion and
chorion), decidua and placenta at term, we demonstrate
that the major isoform present in the fetal membranes
and placenta is a cytoplasmic 60 kDa isoform, an isoform
of molecular mass identical to that of PR-C, that PR-B or
PR-A are not expressed in the amnion or chorion, and that
the 94 kDa PR-A protein is the dominant PR isoform in
the decidua.
Methods
Patient samples
Local Research Ethics Committee approval for the study
was obtained and all patients signed informed consent for
their tissues to be used. Fetal membranes and placenta (n
= 6) were collected from term patients undergoing elective
Caesarean section prior to labour. All tissues were divided
into 3 parts; one fixed in formalin and embedded in par-
affin for histological examination, the other two snap-fro-
zen in liquid nitrogen and stored at -80°C for later RNA
and protein extraction. Enriched amnion was obtained by
careful peeling of the amnion away from the chorion and
decidua. Enriched decidua was obtained using the edge of
a microscope slide to carefully remove a thin layer from
the inverted fetal membranes. Enriched chorion was
obtained by using the edge of the microscope slide to
scrape away the remaining decidua. A 2 cm3 block of pla-
centa from the mid-part of a cotyledon was taken and
washed briefly with sterile PBS before division into 3
parts.
Immunohistochemistry
Five μm sections of tissue dried for 48 hr prior to de-wax-
ing and re-hydration through graded alcohol to distilled
water were subjected to boiling 10 mM citric acid for 12
min followed by cooling for exactly 20 min before transfer
into cold H2O to retrieve antigenic sites. Endogenous per-
oxidase activity and specific binding was blocked with 6%
peroxide for 15 min, followed by incubation with non-
immune rabbit serum (10% in phosphate buffered saline
(PBS)) for 30 min, respectively. Endogenous avidin and
biotin sites were blocked with Avidin-Binding blocking
solutions (Vector Laboratories, Peterborough, UK)
according to the manufacturer's instructions. Antibodies
that detect all known isoforms of PR, clone 1A6 and C-20,
were purchased from Novacastra Laboratories, Newcastle-
upon-Tyne, UK and Santa Cruz Biotechnologies, Santa
Clara, CA, USA, respectively. The antibodies that detect
only PR-B (San27) and antibodies that detect only PR-A
(clone 16) in immunohistochemistry were purchased
from Novacastra. Monoclonal antibodies diluted in 10%
non-immune rabbit serum, at 1:50 (1A6), 1:150 (San27),
1:200 (clone 16) dilutions, and the polyclonal antibody
C-20 diluted to 1:40 in 10% swine serum, were applied to
sections and incubated overnight at 4°C. In some studies,
C-20 antibodies were pre-incubated (3 hr at room temper-
ature) with a 7-fold excess of immunising peptide before
use. After thorough washing in PBS, biotinylated rabbit
anti-mouse or swine anti-rabbit secondary antibodies
(1:400) were applied for 1 hr 30 min, the sections washed
and avidin-biotin complexes applied for 30 min. ColourReproductive Biology and Endocrinology 2009, 7:22 http://www.rbej.com/content/7/1/22
Page 3 of 11
(page number not for citation purposes)
was developed over antigenic sites using 3, 3'-diami-
nobenzidine for 5 min. After copious washes in deionised
water, sections were lightly counterstained with haema-
toxylin, dehydrated through graded alcohols, cleared in
xylene and permanently mounted in XAM (BDH, Poole,
UK). Photomicrographs were obtained at the indicated
magnifications on a Zeiss Axioplan compound micro-
scope (Zeiss, Welwyn Garden City, UK) fitted with a Sony
DN-100 digital camera (Nikon, Kingston-upon-Thames,
UK). Images were digitally enhanced using proprietary
software.
RNA preparation and RT-PCR
Total cellular RNA was obtained from 100 mg of tissue
using Trizol reagent (Invitrogen, Paisley, UK) according
the manufacturer's instructions, and genomic DNA con-
tamination removed by treating the samples with RNase-
free DNase 1 (Promega, Southampton, UK) for 1 hour at
37°C, followed by phenol-chloroform extraction and iso-
propanol precipitation. After verification of RNA quality
by UV-spectrophotometer analysis and agarose gel elec-
trophoresis, one μg of RNA was reverse transcribed using
avian myeloblastosis virus reverse transcriptase (AMV-RT)
for one hr at 42°C. A minus AMV-RT control was obtained
by substituting diethylpyrocarbonate (DEPC)-treated
water for the AMV-RT enzyme.
PCR was performed using PR primer combinations that
identified all PR isoforms, the PR-B isoform, the PR-A and
PR-B isoforms or the PR-S isoform [26]; (Table 1).
Western blotting
Protein extracts were obtained by homogenising samples
in ice-cold lysis buffer (1% Igepal, 0.5% sodium deoxy-
cholate, 0.1% sodium dodecyl sulphate (SDS), 2 mM
EDTA, 50 mM sodium fluoride, 1 mM sodium metavana-
date, 0.2 mg/ml aprotinin all from Sigma-Aldrich, Poole
UK, in PBS (pH 7.0) but without phenyl methyl sulpho-
nyl fluroride) [27]. After incubation on ice for 30 min,
insoluble material was removed by centrifugation at
14,000 g for 20 min at 4°C and supernatants stored at -
20°C. One hundred μg of protein per lane was resolved by
7.5% SDS-polyacrylamide gel electrophoresis, transferred
to nitrocellulose membranes (Amersham-Pharmacia Bio-
tech, Chalfont St Giles, UK) and probed with anti-PR anti-
bodies 1:50 (clone 1A6) or 1:400 (C-20) in 3% Blotto.
Peroxidase-conjugated secondary antibody (Amersham)
was used at a 1:2000 dilution and the reaction visualised
using ECL detection kits. Negative controls were per-
formed with blots not exposed to primary antibody and
by incubation of antibodies with a 7-fold excess of immu-
nising peptide or extracts produced from choriocarci-
noma (BeWo) cells transiently transfected with the
human PR-C [13] expression plasmid.
Results
To investigate the PR isoform repertoire of the progester-
one-dependent human fetal-maternal interface, immuno-
histochemical analysis using the commercial PR antibody
clones 1A6 and C-20 generated towards the ligand- and
DNA-binding domains, respectively, of the full length PR-
B isoform were used (Figs 1 and 2). The data revealed the
presence of cytoplasmic staining in the amnion epithelial
cell, the chorionic trophoblast and the maternal decidual
cell. Nuclear staining with these antibodies was only
found in decidual cells and positive control tissues such as
breast cancer, endometrium and myometrium (positive
control data not shown). No nuclear staining was
detected in the amnion epithelium and chorionic cytotro-
phoblast (Figs 1 and 2). The connective tissue cells of the
reticular and chorionic layers of the fetal membrane were
devoid of any immunoreactivity (Fig 1a). In the placenta,
the syncytiotrophoblast also demonstrated cytoplasmic
staining with this antibody and no nuclear staining (Fig
2a). However, cytoplasmic and nuclear immunoreactivity
was observed in decidual cells attached to the basal plate
(Fig 2a).
To confirm the identity of the cytoplasmic isoform found
in these cell types, immunostaining with PR-B- and PR-A-
Table 1: Designation and sequences of primers used in RT-PCR.
Primer Sequence Combinations Size (bp) Detects
pB5' CCTGAAGTTTCGGCCATACCT p15 & p35 284 B, A, C, M & S
pB3' AGCAGTCCGTGTCCTTTCT p33 & p36 396 B & A
pS GAATTCAGGAGAGTGGGTGCTC pS & p33 186 S
p15 AGGAGTTTGTCAAGCTTCAA pB5' & pB3' 197 B
p33 GAATTCATTTGGAACGCCCACTGG
p35 CTGCAGGGACTGGATAAATGTATTC
p36 CTGCAGGTCTACCCGCCCTATC
gapdf AGAACATCATCCCTGCCTC gapdf & gapdr 347 GAPDH
gapdr GCCAAATTCGTTGTCATACC
Primer combinations, expected amplicon size, reaction conditions and isoforms detected are shown in Fig 2 and are described in references 26 and 
33. GAPDH, Glyceraldehyde-3-phosphate dehydrogenase.Reproductive Biology and Endocrinology 2009, 7:22 http://www.rbej.com/content/7/1/22
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specific antibodies revealed nuclear staining in the decid-
ual cell, but no other staining elsewhere in the fetal mem-
brane (Figs 1 and 2). Similarly, nuclear staining was
confined only to the decidual cells of the basal plate
attached to the placenta (Fig 2c). Nuclear staining in clas-
sical progesterone target tissues (breast cancer, endome-
trial, and myometrial cells) confirmed the PR-B and PR-A
specificity of the antibodies (data not shown). The conclu-
sion from these studies was that the cytoplasmic isoform
found within fetal membranes, decidua and the syncytio-
trophoblast of the placenta was neither the PR-B nor the
PR-A isoform and could represent one of the other PR iso-
forms. These data were inconsistent with previous obser-
vations that the amnion epithelial cell contained both PR-
B and PR-A isoforms and that during labour there is a loss
of the PR-B isoform in favour of the PR-A isoform [23],
but is consistent with the immunohistochemical studies
of Goldman et al. [25].
To find the identity of the cytoplasmic progesterone recep-
tor isoform, RNA extracts prepared from term fetal mem-
brane and placenta samples were subjected to RT-PCR
with several isoform-specific primer sets (Table 1) and
revealed the presence of a PR transcript in all samples by
Identification of PR-positive cell types at the fetal-maternal interface Figure 1
Identification of PR-positive cell types at the fetal-maternal interface. (Panel a) Low power image of fetal mem-
branes showing the immunohistochemical staining patterns obtained with antibodies that detect all isoforms of PR (clone 1A6) 
and (C-20), antibodies that detects only PR-B (San27) and antibodies that detect only PR-A (clone 16). An equivalent amount of 
mouse immunoglobulins (IgG) or antibody pre-adsorbed with immunising peptide (BP), against which C-20 antibodies were 
generated, indicates specificity. Immunoreactivity is indicated with the black arrows in the amniotic (a), the star in the chorionic 
(c) and with red arrows in the decidual (d) layers of the fetal membranes. (Panel b) The presence of cytoplasmic PR and an 
absence of PR-B and PR-A isoforms are demonstrated in term amnion epithelial cells (1, 4, 7, and 10), and chorionic cytotro-
phoblasts (2, 5, 8, and 11). Both cytoplasmic and strong nuclear staining was observed in the decidua (3, 6, 9 and 12) indicating 
the presence of cytoplasmic and nuclear PR isoforms. Bar = 50 μm; Data are representative of six independent samples.Reproductive Biology and Endocrinology 2009, 7:22 http://www.rbej.com/content/7/1/22
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RT-PCR (Figs 3 and 4; top panels). Analysis with PR-B-,
PR-A and/or PR-B- and PR-S-specific primer sets showed
that fetal membranes with decidua attached consisted
mainly of PR-A transcripts with some transcripts for PR-B,
but no PR-S transcripts (Figs 3 and 4). Fetal membranes
enriched for amniochorion revealed the presence of a
transcript for PR that was not PR-B, not PR-A or PR-S lead-
ing to conclusion that the cytoplasmic PR isoform present
was either PR-C or PR-M previously observed in human
breast cancer cells and isolated from human aortic
endothelial cells, respectively [9,13,28,29]. The placenta
similarly contained a transcript for PR that was mainly PR-
A, although transcripts for PR-B were also detected (Figs 3
and 4). Transcripts for PR-S were undetectable, except in
the T47D breast cancer cell control. Samples enriched for
decidua revealed the presence of all PR isoforms including
PR-S (Fig 4), whereas the amnion lacked transcripts for
PR-A, PR-B and PR-S and the chorion (which is often con-
taminated with decidua) produced a major band for PR-
A, although small amounts of transcripts for PR-B and PR-
S were also detected (Fig 4).
When protein extracts from partially purified fetal mem-
branes, placenta, trophoblasts and decidua were com-
pared with those from T47D breast cancer cells, using
western blotting techniques with the PR antibodies that
Cellular localisation of PR isoforms Figure 2
Cellular localisation of PR isoforms. (Panel a) High power images of PR immunostaining with clone 1A6 indicating immu-
noreactivity in the cytoplasm of the amnion epithelial cell and the chorionic cytotrophoblast. Note the absence of staining in 
the blue nucleus of either cell type. The plasma membrane of the cell is shown by the arrows, the apical surface by the white 
asterix and a void between the nucleus and the cytoplasm by the red V. (Panel b) A low power image of PR immunostaining 
of the term placenta with clone 1A6 antibodies indicating immunoreactivity in the syncytiotrophoblast layer (arrow), but 
absent elsewhere. (Panel c) High power images of PR immunostaining of term placenta indicating the presence of cytoplasmic 
PR in the syncytiotrophoblast but not nuclear PR-B and PR-A isoforms (panel c; 1, 2, and 3); whereas basal plate decidual 
cells contained both cytoplasmic and nuclear PR isoforms (4, 5, and 6 arrowed). These data suggest the cytoplasmic PR stain-
ing in amnion epithelial cells, cytotrophoblasts, syncytiotrophoblasts and decidual cells, is not PR-B or PR-A, but PR-S, PR-M or 
PR-C. Bar = 50 μm, except panel A where Bar = 5 μm. Data are representative of six independent samples.Reproductive Biology and Endocrinology 2009, 7:22 http://www.rbej.com/content/7/1/22
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detected the cytoplasmic isoform in the immunohisto-
chemistry studies (Figs 1 and 2; Table 2), several PR
immunoreactive proteins were observed in T47D breast
cancer cell extracts in line with previous studies
[6,11,25,27,30], whereas the tissues at the fetal maternal
interface revealed a major PR isoform with a relative
molecular mass of ~60 kDa (Fig 5). Other progesterone
target tissues, such as endometrium (data not shown) and
myometrium possessed the 116 kDa PR-B, 94 kDa PR-A
and 60 kDa isoforms but only with the C-20 antibody,
although weak bands were present with the 1A6 mono-
clonal antibody (Fig 5).
The data indicate the presence of a major PR isoform of
~60 kDa in all the fetal membrane samples and that tis-
sues 'contaminated' with decidua were devoid of signifi-
cant levels of the PR-B but contained small amounts of
PR-A isoforms that are easily detected in myometrium and
T47D cell controls. Placenta and term decidua also indi-
cated the presence of a ~60 kDa protein as the major PR
isoform although other PR-isoforms were observed. Using
the 1A6 antibody, the 38 kDa PR-M isoform was only
observed in the tissues contaminated with deciduas and
T47D extracts, whereas it was visualised in all samples
with the C-20 antibodies.
Discussion
The role of progesterone receptors in human gestation
and parturition is to mediate the actions of progesterone
so as to maintain pregnancy. In most mammals, the sta-
bility of the relationship in the fetal-maternal interface is
disturbed by the fall of progesterone production by the
placenta, with the concomitant softening of the cervix,
rupture of the fetal membranes and initiation of highly
synchronised high-pressure contractions of the myo-
metrium that characterises labour [31]. In the human,
similar events occur in the same coordinated manner
except there is no decrease of systemic progesterone con-
centration [31]. A hypothesis presented [32], that a
'switch' in PR isoforms from the more transcriptionally
dominant PR-B to the less active PR-A isoform must there-
fore occur in these tissues, has been convincingly sup-
ported by evidence in the myometrium [32,33], and in
the cervix [34,35] and less convincingly in the amnion
and maternal decidua [25].
In the present study we have shown that human fetal
membranes (amnion epithelial cell and chorionic
cytotrophoblast) contain mainly high levels of a 60 kDa
PR isoform (Figs 1 and 2; Table 2) that could be PR-C
[5,6,25,27,28,36] or a different isoform that is initiated
from the AUG codon at amino acid 301 of the full length
protein sequence [7], whereas the placental cytotrophob-
last is devoid of PR and the placental syncytiotrophoblast
contains only this cytoplasmic isoform. By contrast, the
maternal decidua contains not only PR-A, as its major iso-
form, but also PR-B, PR-S and the cytoplasmic isoform.
These data differ from those recently reported [25] where
PR-B and PR-A isoforms were observed in amnion nuclear
extracts yet, paradoxically, the antibody used failed to
show immunoreactive PR by immunohistochemistry and
theoretically, should not detect the PR-C, PR-S, or PR-M
isoforms in western blotting, as the epitope for this anti-
Evidence that the PR isoform in human fetal membranes and  placenta at term is either PR-C or PR-M Figure 3
Evidence that the PR isoform in human fetal mem-
branes and placenta at term is either PR-C or PR-M. 
RT-PCR products generated from fetal membrane samples 
that had decidua attached (FM + dec) or fetal membranes 
that had the decidua scraped away (FM – dec) or term pla-
centa (Plac). One μg of DNase-treated total RNA was 
reverse transcribed in the presence (+), or absence (-), of 
AMV-RT. Both samples were then amplified in a PCR with 
isoform-specific primers (see Table 1) that detected all 
known PR isoforms; the PR-B isoform alone; a combination 
of PR-A and PR-B; or the PR-S isoform alone. GAPDH was 
used a control for efficiency of mRNA manipulation and PCR 
amplification. Myometrium (myo) was used as a positive 
control for PR with T47D cell extract as a positive control 
for PR-S (separate column), and in all cases a minus RT 
sample was incorporated to rule out the presence of con-
taminating genomic DNA. Results are representative of four 
independent assessments. Data show the presence of PR in 
all 4 tissue samples and T47D cells.Reproductive Biology and Endocrinology 2009, 7:22 http://www.rbej.com/content/7/1/22
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body is found only at the N-terminal region of the PR-A
isoform [37]. However, this epitope is present in the
PR301 protein and thus that particular antibody could be
targeting this protein. In the present study, no PR-B or PR-
A isoforms were detected in the amnion or chorion and
the hypothesis that progesterone receptor switching
occurs within these tissues at term or in labour [23] is not
supported. Although, we cannot rule out the presence of a
small amount of PR-B or PR-A isoforms being present in
the nuclei of amnion epithelial cells, despite a lack of
expression of these isoforms at the mRNA level (Figs 3 and
4), the present study indicates that PR-B and PR-A are of
little importance in relation to the 60 kDa isoform in fetal
membranes. Additionally, the PR immunoreactivity in the
present study that we consider represents either the C or
PR301 isoform, was confined to the cytoplasm of the
amniotic epithelium and the chorionic cytotrophoblast,
and was the major isoform present, whereas no cytoplas-
mic immunoreactivity was detected in the aforemen-
tioned study [25]. These data are qualitatively similar to
that obtained in the baboon [38], where PR was not
observed in the amnion or chorion, but strong nuclear
and weak cytoplasmic staining was observed in the
decidua with the JZB39 rat anti-PR monoclonal antibody.
Observations obtained with JZB39 [39], which has been
shown to only detect the 60 kDa isoform in myometrium
and not T47D extracts by immunoblotting, were depend-
ent upon protein concentrations [39]. These data suggest
that protein loading in immunoblotting is critical for
good detection of the 60 kDa isoform. Indeed, this iso-
form was weakly represented on western blotting in a pre-
vious study [25], whereas our data show intense
expression of the 60 kDa isoform (Fig 5) for this exact rea-
son. Alternatively, these discrepant observations may be
related to the antibodies used, the use of nuclear extracts
compared to whole cell extracts or the presence of con-
taminating cytoplasm/tissues in the previous study [25].
Indeed, there is confusion in the literature concerning the
use and specificity of available PR antibodies with some
antibodies lacking specificity for particular PR isoforms
[7,19], despite the evidence provided by the suppliers that
the antibodies are specific. For example, the C-20 polyclo-
nal antibody we used herein is marketed showing 4 dis-
tinct bands on western blots for PR in T47D cell extracts.
Yet Salamecos & Gellersen could not demonstrate any PR-
specific bands in T47D cell extracts, COS-7 cells or in vitro
translated products with the C-20 antibody [7]. We have
demonstrated the same distinct 4 PR isoforms using our
T47D extracts with this antibody, including a strong band
for PR-B, yet no PR-B protein was present from proteins
generated from the extra-embryonic tissue extracts,
despite the presence of transcripts for PR-B (Figs. 3 and 4).
This could be due to either the loss of translation from the
AUG codon at amino acid 1 in these cells, that T47D cells
differ from laboratory to laboratory or protein degrada-
tion occurred during the preparation of samples. The lat-
ter option is unlikely, because myometrial tissue prepared
in the same way as the extra embryonic tissues also pro-
duced PR-B protein on our blots (Fig 5.). The conclusion,
therefore, is that the 60 kDa protein detected is generated
from a primary translation site in these tissues that arises
from either the AUG codon at amino acids 301 or 595.
RT-PCR gels showing the PR transcripts found in extracts of  enriched amnion (amnion), chorion (chorion) and decidua  (decidua) Figure 4
RT-PCR gels showing the PR transcripts found in 
extracts of enriched amnion (amnion), chorion (cho-
rion) and decidua (decidua). Data were obtained from 
the +RT sample only and indicate that the amnion contains a 
PR transcript that is not PR-A or PR-B. Additionally, enriched 
decidua contains the PR-S isoform whereas the chorion 
(which is contaminated with decidua) also contains PR-S, PR-
B and PR-A. The amnion does not contain these transcripts, 
but does contain a PR isoform. The bands visible at the bot-
tom of the 186 bp PR-S isoform gel are unused primers.Reproductive Biology and Endocrinology 2009, 7:22 http://www.rbej.com/content/7/1/22
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In agreement with our studies, Goldman et al. [25]
showed that PR-A is expressed in the nucleus of the
decidua but absent in the amnion by immunohistochem-
istry, but paradoxically, found all isoforms present by
western blotting. By contrast, our western blot studies
indicate the major PR isoform in the fetal membranes
(amnion and chorion) is a 60 kDa protein that could be
the PR-C isoform and that it is localised within the cyto-
plasm, without immunoreactivity within the nuclei of the
same cells and, therefore, we consider that the relevance of
the changes in levels of the PR isoforms detected within
the amniotic nuclear extracts of labour [25], should be
considered with caution.
Using antibodies that detect all known PR isoforms, we
demonstrated that the major isoform in the amnion, cho-
rion and syncytiotrophoblast is the 60 kDa isoform (Fig
5). This isoform was previously reported as the PR-C iso-
form in human breast cancer cells [5,6,28], human fetal
membranes [25], the rat decidua basalis [40] and the
guinea pig cervix [27], suggesting that the ~60 kDa PR pro-
tein in the amniochorion and placenta is PR-C (Fig 5).
The absence of PR-B and PR-A transcripts in amniochor-
ion, which was devoid of decidua (Figs 3 and 4), con-
firmed these findings. By contrast, the major isoform in
the decidua is considered to be PR-A [41], but in this study
PR-B, PR-S and the 60 kDa isoforms are also expressed
(Figs 3, 4 and 5). In light of the study by Goldman et al.,
these data need further clarification, but suggest that the
60 kDa PR isoform is an important molecule in the fetal
membranes, decidua and syncytiotrophoblast. These data
also suggest that a re-evaluation of the roles of PR in the
fetal-maternal interface is needed and the idea that PR-A
simply acts as a dominant negative regulator of PR-B
action is not applicable to these particular tissues [23].
The exact mechanism involved in the synthesis of the N-
truncated PR isoforms that include PR-C is unknown, but
limited evidence suggests that PR-C may be produced
using a third oestrogen dependent promoter that replaces
both exon 1 and exon 2 of the full length PGR gene [42],
with an AUG codon at amino acid 595 being the transla-
tional start site in a number of mammalian and non-
mammalian species [5,27,28,42-44]. The demonstration
that PR-C isoforms in the human breast cancer cell do not
arise from proteolysis of larger PR-isoforms [13] but from
two specific PR transcripts that originate from a 11.4 kb
complex [5] and that specific PR mRNA transcripts are
present in human fetal membranes and placenta that are
not any of the other recognised PR isoforms (this study),
Evidence that the major PR isoform in human fetal membranes at term is the 60 kDa isoform Figure 5
Evidence that the major PR isoform in human fetal membranes at term is the 60 kDa isoform. (Panel a) Protein 
extracts from fetal membrane samples that had decidua attached (lane 1) and fetal membranes that had the decidua scraped 
away (lane 2) were compared with extracts from term amnion (lane 3), chorion (lane 4) and decidua (lane 5) that were 
obtained from crude tissue separation methods and from term placenta (lane 6), myometrium (lane 7) and breast cancer 
(T47D cell) extracts (lane 8). The antibody clones used were 1A6 (upper series) and C-20 (lower series) that detect all PR 
isoforms (see lane 8). (Panel b) Confirmation that the antibodies detect the 60 kDa PR-C isoform was obtained by immunob-
lotting an extract obtained from human choriocarcinoma (BeWo) cells transiently transfected with a human PR-C expression 
plasmid and probed with C-20 antibodies (-) or C-20 antibodies pre-adsorped with immunising peptide (+).Reproductive Biology and Endocrinology 2009, 7:22 http://www.rbej.com/content/7/1/22
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strongly suggests that the 60 kDa isoform is generated
through promoter specific transcription in extra-embry-
onic tissues. The function of N-truncated PR isoforms
including PR-C is unclear, although they may act as mod-
ulators of PR-A and PR-B transcriptional activities in those
cells that produce these isoforms [13]. In the human
amnion and chorion, dominant negative regulation of
PR-B and PR-A transcriptional control seems unlikely in
the absence of any measurable PR-A or PR-B isoforms and
point towards PR-C specific functions. Because PR-C lacks
a full DNA binding domain [13], but has a nuclear local-
isation signal and two dimerisation domains [42], the
intriguing possibility that PR-C may associate with other
transcriptional elements to modulate gene transcription is
raised [13]. Indeed, evidence exists in the rat myometrium
that during labour the 60 kDa PR-C isoform translocates
from the cytoplasm into the nucleus [18,36]. Addition-
ally, studies on the promoter activities of PR-B, PR-A and
a truncated PR that is equivalent to PR-C have demon-
strated that a PR-C-like construct has 3-times the activa-
tion potential of PR-B and 1.5-fold the activation of PR-A
on stimulation with medroxyprogesterone acetate in early
secretory phase human stromal cells [45] and enhances
PR-B and PR-A transactivation in breast cancer cells [13]
suggesting that PR-C may have gene modulatory func-
tions that differ to those of PR-B and PR-A in certain cell
types, as has been shown for the main PR isoforms in a tis-
sue-specific context [46-48]. The 60 kDa protein identi-
fied in this study may not be the PR-C isoform that
originates from the AUG codon at 595, as presented in the
literature, but an isoform that originates at the AUG
codon at 301 [7]. However, the weight of evidence in the
literature currently suggests that it is most likely PR-C;
indeed, the demonstration that protein produced from
the original PR-C plasmid cloned from a cDNA library
produced a 60 kDa band on western blot (Fig 4) supports
this. PR-C plasmids generated from PCR products gener-
ated from a PR-B containing plasmid produce proteins of
only 38 kDa [7], consistent with the molecular mass of
PR-M, although the authors suggest that proteins for PR-
M, PR-S, PR-C and PR-T isoforms do not exist, suggesting
that more research into the nature of proteins produced
from these expression plasmids is required. However, the
cytoplasmic location and relatively high levels of this 60
kDa protein in the amniochorion are suggestive of a local-
ised function in the cytoplasm rather than a nuclear
genomic function for this tissue and that this localisation
is important for sustained gestation. It now seems imper-
ative that the identity, regulation and role of the 60 kDa
cytoplasmic PR isoform are investigated to further our
understanding of the role of progesterone in these tissues
in relation to human parturition.
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